drugset / Trial / NCT05801289
Quetiapine as Prophylaxis for Delirium in CABG
RandomizedParallel-groupOpen-labelPrevention
Summary
low-dose quetiapine may be effective in preventing delirium in patients. The purpose of this study is to evaluate the efficacy and safety of quetiapine for delirium prophylaxis in cabg
Timeline
- Start
- 2022-12-04
- Primary completion
- 2023-04
- Completion
- 2023-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Quetiapine | Small molecule | 25 mg | — |